Easy To Use Patents Search & Patent Lawyer Directory
At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Searching:
Search by keyword, patent number, inventor, assignee, city or state:
| Patent # | Description |
|---|---|
| US-9,517,272 |
Temperature dependent activation of catalytic nucleic acids for controlled
active substance release The present invention relates to an active substance release system containing two compounds. The first compound comprises a nanoparticle, combined with an... |
| US-9,517,271 |
Oral drug delivery system Dosage forms and drug delivery devices suitable for administration of pharmaceutical compounds and compositions, including the oral drug administration of... |
| US-9,517,270 |
Lipocationic polymers and uses thereof Polymers produced by ring opening polymerization which comprises an amino group that can be used in compositions to deliver a nucleic acid such as a miRNA or a... |
| US-9,517,269 |
Stable pentobarbital formulation The present invention relates to a pentobarbital formulation with greater stability and fewer impurities. In particular, the formulation may be an aqueous... |
| US-9,517,268 |
Process for producing inorganic particulate material The present invention is directed to a process for producing inorganic particulate material, the material obtainable by such process, a modified release... |
| US-9,517,267 |
Photodynamic diagnostic agent and photobleaching inhibitor The objects of the present invention are to inhibit photobleaching of porphyrins as well as to provide a superior photodynamic diagnostic agent and a... |
| US-9,517,266 |
Liquid formulation containing a protein drug Disclosed is a method of preparing a stabilized liquid formulation of a protein drug, comprising admixing a protein drug with a composition for stabilization,... |
| US-9,517,265 |
Methods for the prevention and/or treatment of memory impairment The present invention relates to methods for the prevention and/or treatment of memory impairment and for improving memory and particularly to methods for the... |
| US-9,517,264 |
Human FGF receptor and .beta.-Klotho binding proteins The present invention provides compositions and methods relating to or derived from antigen binding proteins and antigen binding protein-FGF21 fusions that... |
| US-9,517,263 |
Benzonaphthyridine-containing vaccines The invention provides, inter alia, immunogenic compositions that comprise (a) a first antigen, (b) polymeric particles and (c) a benzonaphthyridine compound,... |
| US-9,517,262 |
Vaccine injection, preparation method and use thereof The invention provides a vaccine injection, which includes a vaccine and a Traditional Chinese medicinal adjuvant in a mass ratio of 1:0.5-1:10, or a vaccine, a... |
| US-9,517,261 |
Second generation virus-like particles (VLP) from Epstein-Barr viruses for
vaccination purposes The present invention relates to an Epstein-Barr virus-like particle (EB-VLP) substantially free of Epstein-Barr Virus (EBV) DNA. The present invention also... |
| US-9,517,260 |
Treatment of pigs with PCV2 antigen The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated... |
| US-9,517,259 |
West Nile Virus vaccine The invention provides for immunogenic compositions against West Nile Virus. The immunogenic compositions, in alternate embodiments, also include other equine... |
| US-9,517,258 |
Methods and materials for treating cancer This document provides methods and materials for treating cancer. For example, methods and materials for identifying antigens and combinations of antigens that... |
| US-9,517,257 |
Erythrocyte-binding therapeutics Peptides that specifically bind erythrocytes are described. These are provided as peptidic ligands having sequences that specifically bind, or as antibodies or... |
| US-9,517,256 |
Vaccine and method for treatment of neurodegenerative diseases Methods and compositions are provided for treatment of neurodegenerative diseases in which there is accumulation of misfolded and/or aggregated proteins,... |
| US-9,517,255 |
Process, tube and device for the preparation of wound healant composition The present invention is related to the field of tissue regeneration. It concerns more particularly new processes, tubes and devices for thrombin, platelet... |
| US-9,517,254 |
Treatment regimens The invention further relates to compounds, pharmaceutical compositions and methods for treating all disorders of human sexual function including hypoactive... |
| US-9,517,253 |
Compositions for treating multiple sclerosis Compositions comprising Tr1 cells directed to a multiple sclerosis associated antigen and methods for treating multiple sclerosis. |
| US-9,517,252 |
p53 activating peptides The present invention is directed to p53 activating peptides. The present further describes methods for generating these peptides and the use of these peptides. |
| US-9,517,251 |
Methods for generating cardiomyocytes The present disclosure provides method of generating cardiomyocytes from post-natal fibroblasts. The present disclosure further provides cells and compositions... |
| US-9,517,250 |
Methods for generating cardiomyocytes The present disclosure provides method of generating cardiomyocytes from post-natal fibroblasts. The present disclosure further provides cells and compositions... |
| US-9,517,249 |
Antioxidant dietary supplement and related method A supplement including a blend of turmeric, quercetin and rosemary, or holy basil, wasabi, and broccoli seed extract which are present in a balanced and... |
| US-9,517,248 |
Adherent cells from adipose or placenta tissues and use thereof in therapy A method of treating ischemia in a subject in need thereof is disclosed. The method comprising administering to the subject a therapeutically effective amount... |
| US-9,517,247 |
Encapsulated liver cell composition Microcapsules including a capsule shell encapsulating a suspension of a therapeutically effective amount of liver cells in physical contact with a liver cell... |
| US-9,517,246 |
Chitosan derivatives for inactivation of endotoxins and surface protection
of nanoparticles The present disclosure provides a polymer comprising a derivative of chitosan, wherein the derivative is zwitterionic, as well as methods of using the polymer.... |
| US-9,517,245 |
Sorafenib-microRNA combination therapy for liver cancer A method of treating a subject having liver cancer can include administering a synthetic oligonucleotide to a subject having liver cancer, the oligonucleotide... |
| US-9,517,244 |
Therapeutic combinations for use in neoplasia The invention features compositions and methods that are useful for the treatment of neoplasia (e.g., pancreatic cancer, colon cancer, brain cancer) by... |
| US-9,517,243 |
Beta-mannosylceramide and stimulation of NKT cell anti-tumor immunity .beta.-mannosylceramides or salts or solvates thereof in a pharmaceutically acceptable carrier, for use as a Type I NKT cell agonist in conjunction with a... |
| US-9,517,242 |
Dosage forms for oral administration of zoledronic acid or related
compounds for treating disease Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The bioavailability of... |
| US-9,517,241 |
Amelioration of intestinal fibrosis and treatment of Crohn's disease Methods of treating patients with inflammatory bowel disease, intestinal fibrosis, or Crohn's disease involve administering a therapeutic amount of CARD-024 or... |
| US-9,517,240 |
Methods and compositions for cancer prevention and treatment The present invention provides methods of preventing or delaying the development of cancer (e.g., breast cancer) in BRCA1 mutation positive patients by... |
| US-9,517,239 |
High-purity large-scale preparation of stannsoporfin Large scale (bulk) compositions comprising high-purity stannsoporfin are disclosed, as well as methods of synthesizing such compositions. |
| US-9,517,238 |
Compositions and methods for treating allergic inflammation through
inhibition of NTRK1 The invention provides methods of treating allergic inflammatory conditions using an anti-neurotrophin tyrosine kinase receptor 1 (NTRK1)-based therapeutic... |
| US-9,517,237 |
Compounds and methods for treating multiple sclerosis The invention described herein pertains to the treatment of multiple sclerosis. In particular, the invention described herein pertains to the treatment of... |
| US-9,517,236 |
Controlled release hydrocodone formulations A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a... |
| US-9,517,235 |
Methods for treating antipsychotic-induced weight gain The present invention relates to the discovery of a novel opioid modulator effective in reducing pharmacologically induced weight gain associated with atypical... |
| US-9,517,234 |
Tetrandrine family pharmaceutical formulations and method Drug formulations, methods and their use in treatment of diseases using formulations of pure di-acid salts of tetrandrine family members, especially... |
| US-9,517,233 |
Local cochlear application of statins for stimulating neurite regrowth in
the cochlea Statin compositions are disclosed for stimulating neurite growth from spiral ganglion neurons in the inner ear, as well as methods and kits for preventing... |
| US-9,517,232 |
Compounds for treatment of alzheimer's disease The invention is directed to the use of a compound of formula I, as defined herein, to a pharmaceutically acceptable salt thereof; to a pharmaceutical... |
| US-9,517,231 |
Methods and pharmaceutical compositions for the treatment of symptoms of
anxiety and panic using beta... The present invention is focused primarily toward pro re nata ("as needed") treatments for a psychiatric condition or disorder or the symptoms thereof,... |
| US-9,517,230 |
Small molecule RNase inhibitors and methods of use Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the... |
| US-9,517,229 |
Treatment of breast cancer The disclosure describes the use of one or more compounds that fall within the scope of one or more of structural formulae I, II, III, IV, V, or VI for treating... |
| US-9,517,228 |
Cannabinoid receptor antagonists/inverse agonists useful for treating
metabolic disorders, including obesity... The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and... |
| US-9,517,227 |
Dihydropyrazoles Novel dihydropyrazole derivatives of formula (I) ##STR00001## wherein L, R, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, X.sup.1, X.sup.2, X.sup.3, X.sup.4,... |
| US-9,517,226 |
Inhibitors for treating diseases characterized by atrial enlargement or
remodeling The present invention relates to the NEP inhibitor pro-drug N-(3-carboxy-1-oxopropyl)-(4S)-p -phenylphenylmethyl)-4-amino-(2R)-methylbutanoic acid ethyl ester,... |
| US-9,517,225 |
Low dose lipoic acid pharmaceutical compositions and methods Compositions containing low doses of lipoic acid-based active agents and methods for using the same are provided. In particular, compositions containing low... |
| US-9,517,224 |
Methods of treating patients infected with HIV and HTLV Disclosed is a method of activating protein kinase C theta (PKC.theta.) in an HIV or HTLV infected animal comprising administering to the animal an effective... |
| US-9,517,223 |
Methods to treat neurodegenerative diseases The present invention is based on the discovery that motor neurons derived from patients with a neurodegenerative disease have decreased delayed rectifier... |
File A Patent Application
- Protect your idea -- Don't let someone else file first. Learn more.
- 3 Easy Steps -- Complete Form, application Review, and File. See our process.
- Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.